You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Therapy Areas
Novartis to build new radioligand therapy site in Texas
Login
Username:

Password:


Related Headlines

Coiled Therapeutics reports enhanced efficacy for AO-252 and accelerates transition to dose expansion

IDEOlogy Health and West Cancer Center partner to advance patient-centred oncology education and care

Lupin's Dapagliflozin Tablets receive US regulatory approval

Insmed reports Phase 2b study of brensocatib did not meet efficacy endpoints

Dexcel Pharma's Nintedanib Capsules approved for US launch

Gilead to acquire Tubulis to expand ADC oncology capabilities

FDA grants Fast Track status to SIM0505 for platinum‑resistant ovarian cancer

Alloy Therapeutics and Biogen expand partnership with multi-target antisense collaboration

Sanofi reports positive phase 2 results for lunsekimig in asthma and CRSwNP

Akeso reports updated data on cadonilimab combination therapy in PD-(L)1 inhibitor-resistant advanced NSCLC data

AstraZeneca reports positive Phase III data for Imfinzi and Imjudo in liver cancer

Caliway to present preclinical data on CBL-514 in combination with GLP-1R therapy at ADA 2026 Scientific Sessions

Mary's Medicinals to participate in CMS trial programme with cannabinoid-based wellness products

Lilly's Foundayo (orforglipron) weight loss pill gains US FDA approval

Thermo Fisher Scientific unveils CHOvantage GS Kit to speed biologics development

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026